Cargando…
多重实时荧光定量PCR法筛查成人Ph样急性淋巴细胞白血病
OBJECTIVE: To investigate the feasibility of multiplex real-time RT-PCR with fluorescent probes in early screening of Ph-like acute lymphoblastic leukemia (ALL) and analyze the clinical feature and prognos. METHODS: A total of 118 adult B-ALL patients diagnosed between October 2010 and March 2016 we...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342795/ https://www.ncbi.nlm.nih.gov/pubmed/29224319 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.11.011 |
_version_ | 1783555595138236416 |
---|---|
collection | PubMed |
description | OBJECTIVE: To investigate the feasibility of multiplex real-time RT-PCR with fluorescent probes in early screening of Ph-like acute lymphoblastic leukemia (ALL) and analyze the clinical feature and prognos. METHODS: A total of 118 adult B-ALL patients diagnosed between October 2010 and March 2016 were enrolled in this study. Multiplex RT-PCR was used to detect the Ph-like ALL related fusion gene and CRLF2 expression in 58 BCR-ABL and MLL rearrangement negative patients. The clinical features, treatment response and prognosis were analyzed in Ph-like fusion gene positive and/or CRLF2 over-expression patients. RESULT: Among 58 patients, 9 patients (9/58, 15.5%) showed Ph-like ALL related fusion genes positive and 10 patients (10/58, 17.2%) showed CRLF2 over-expression. There were statistical differences in age, WBC count, immunophenotypes, cytogenetics and risk stratification among Ph-like fusion gene positive or CRLF2 over-expression patients, Ph(+) patients, MLL(+) patients and B-other patients. The 2-year overall survival rates were 65%, 47%, 64% and 74% respectively among these four groups (P=0.043). The 2-year relapse free survival rates were 51%, 39%, 62% and 70% respectively among these four groups (P=0.010). CONCLUSION: Routine screening of Ph-like ALL by multiplex RTPCR is feasible. |
format | Online Article Text |
id | pubmed-7342795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-73427952020-07-16 多重实时荧光定量PCR法筛查成人Ph样急性淋巴细胞白血病 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To investigate the feasibility of multiplex real-time RT-PCR with fluorescent probes in early screening of Ph-like acute lymphoblastic leukemia (ALL) and analyze the clinical feature and prognos. METHODS: A total of 118 adult B-ALL patients diagnosed between October 2010 and March 2016 were enrolled in this study. Multiplex RT-PCR was used to detect the Ph-like ALL related fusion gene and CRLF2 expression in 58 BCR-ABL and MLL rearrangement negative patients. The clinical features, treatment response and prognosis were analyzed in Ph-like fusion gene positive and/or CRLF2 over-expression patients. RESULT: Among 58 patients, 9 patients (9/58, 15.5%) showed Ph-like ALL related fusion genes positive and 10 patients (10/58, 17.2%) showed CRLF2 over-expression. There were statistical differences in age, WBC count, immunophenotypes, cytogenetics and risk stratification among Ph-like fusion gene positive or CRLF2 over-expression patients, Ph(+) patients, MLL(+) patients and B-other patients. The 2-year overall survival rates were 65%, 47%, 64% and 74% respectively among these four groups (P=0.043). The 2-year relapse free survival rates were 51%, 39%, 62% and 70% respectively among these four groups (P=0.010). CONCLUSION: Routine screening of Ph-like ALL by multiplex RTPCR is feasible. Editorial office of Chinese Journal of Hematology 2017-11 /pmc/articles/PMC7342795/ /pubmed/29224319 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.11.011 Text en 2017年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
spellingShingle | 论著 多重实时荧光定量PCR法筛查成人Ph样急性淋巴细胞白血病 |
title | 多重实时荧光定量PCR法筛查成人Ph样急性淋巴细胞白血病 |
title_full | 多重实时荧光定量PCR法筛查成人Ph样急性淋巴细胞白血病 |
title_fullStr | 多重实时荧光定量PCR法筛查成人Ph样急性淋巴细胞白血病 |
title_full_unstemmed | 多重实时荧光定量PCR法筛查成人Ph样急性淋巴细胞白血病 |
title_short | 多重实时荧光定量PCR法筛查成人Ph样急性淋巴细胞白血病 |
title_sort | 多重实时荧光定量pcr法筛查成人ph样急性淋巴细胞白血病 |
topic | 论著 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342795/ https://www.ncbi.nlm.nih.gov/pubmed/29224319 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.11.011 |
work_keys_str_mv | AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng AT duōzhòngshíshíyíngguāngdìngliàngpcrfǎshāicháchéngrénphyàngjíxìnglínbāxìbāobáixuèbìng |